Publications 2024

Henning O, Ystad Y, Molteberg E, Bjørnvold M, Tschamper MK, Almåsbak G, Nakken KO (2024)
[Education and training on epilepsy for patients and next of kin]
Tidsskr Nor Laegeforen, 144 (2)
DOI 10.4045/tidsskr.23.0794, PubMed 38349105

Publications 2022

Brodtkorb E, Myren-Svelstad S, Arntsen V, Bjørnvold M, Spigset O, Nakken KO (2022)
[Nicotine as a precision treatment for epilepsy]
Tidsskr Nor Laegeforen, 142 (7)
DOI 10.4045/tidsskr.22.0139, PubMed 35510456

Publications 2020

Heger K, Lund C, Larsen Burns M, Bjørnvold M, Sætre E, Johannessen SI, Johannessen Landmark C (2020)
A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway
Epilepsia Open, 5 (3), 432-441
DOI 10.1002/epi4.12413, PubMed 32913951

Johannessen Landmark C, Heger K, Lund C, Burns ML, Bjørnvold M, Sætre E, Johannessen SI (2020)
Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome
Ther Drug Monit, 42 (5), 744-753
DOI 10.1097/FTD.0000000000000781, PubMed 32558674

Lossius K, de Saint Martin A, Myren-Svelstad S, Bjørnvold M, Minken G, Seegmuller C, Valenti Hirsch MP, Chelly J, Steinlein O, Picard F, Brodtkorb E (2020)
Remarkable effect of transdermal nicotine in children with CHRNA4-related autosomal dominant sleep-related hypermotor epilepsy
Epilepsy Behav, 105, 106944
DOI 10.1016/j.yebeh.2020.106944, PubMed 32097883

Publications 2019

Alvestad S, Bjørnvold M, Molteberg E, Lossius M, Landmark CJ (2019)
[Continued importance of valproate for women with generalised epilepsy]
Tidsskr Nor Laegeforen, 139 (7)
DOI 10.4045/tidsskr.19.0220, PubMed 30969058

Systad S, Bjørnvold M, Sørensen C, Lyster SH (2019)
The Value of Electroencephalogram in Assessing Children With Speech and Language Impairments
J Speech Lang Hear Res, 62 (1), 153-168
DOI 10.1044/2018_JSLHR-L-17-0087, PubMed 30950754

Publications 2018

Cockerell I, Guenin M, Heimdal K, Bjørnvold M, Selmer KK, Rouvière O (2018)
Renal manifestations of tuberous sclerosis complex: patients' and parents' knowledge and routines for renal follow-up - a questionnaire study
BMC Nephrol, 19 (1), 39
DOI 10.1186/s12882-018-0835-3, PubMed 29439672

Publications 2017

Cockerell I, Guenin M, Heimdal K, Bjørnvold M, Selmer KK, Rouvière O (2017)
Prevalence of Renal Angiomyolipomas and Spontaneous Bleeding Related to Angiomyolipomas in Tuberous Sclerosis Complex Patients in France and Norway-a Questionnaire Study
Urology, 104, 70-76
DOI 10.1016/j.urology.2017.02.023, PubMed 28232177

Publications 2016

Curatolo P, Bjørnvold M, Dill PE, Ferreira JC, Feucht M, Hertzberg C, Jansen A, Jóźwiak S, Kingswood JC, Kotulska K, Macaya A, Moavero R, Nabbout R, Zonnenberg BA (2016)
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions
Drugs, 76 (5), 551-65
DOI 10.1007/s40265-016-0552-9, PubMed 26927950

Systad S, Bjørnvold M, Markhus R, Lyster SH (2016)
Watch the language! Language and linguistic-cognitive abilities in children with nocturnal epileptiform activity
Epilepsy Behav, 66, 10-18
DOI 10.1016/j.yebeh.2016.09.041, PubMed 27984701

Publications 2015

Tuft M, Årva M, Bjørnvold M, Wilson JA, Nakken KO (2015)
Landau-Kleffner syndrome
Tidsskr Nor Laegeforen, 135 (22), 2061-4
DOI 10.4045/tidsskr.15.0162, PubMed 26627294

Publications 2014

Lund C, Bjørnvold M, Tuft M, Kostov H, Røsby O, Selmer KK (2014)
Aicardi syndrome: an epidemiologic and clinical study in Norway
Pediatr Neurol, 52 (2), 182-6.e3
DOI 10.1016/j.pediatrneurol.2014.10.022, PubMed 25443581

Publications 2009

Bjørnvold M (2009)
Candidate gene studies in type 1 diabetes and other immune-mediated diseases
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 786, 1 b. (flere pag.)
BIBSYS 092698441, ISBN 978-82-8072-316-1

Stene LC, Rønningen KS, Bjørnvold M, Undlien DE, Joner G (2009)
An inverse association between history of childhood eczema and subsequent risk of type 1 diabetes that is not likely to be explained by HLA-DQ, PTPN22, or CTLA4 polymorphisms
Pediatr Diabetes, 11 (6), 386-93
DOI 10.1111/j.1399-5448.2009.00605.x, PubMed 19895409

Publications 2008

Bjørnvold M, Undlien DE, Joner G, Dahl-Jørgensen K, Njølstad PR, Akselsen HE, Gervin K, Rønningen KS, Stene LC (2008)
Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes
Diabetologia, 51 (4), 589-96
DOI 10.1007/s00125-008-0932-0, PubMed 18292987

Publications 2006

Bjørnvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jørgensen K, Njølstad PR, Ek J, Ascher H, Gudjònsdòttir AH, Lie BA, Skinningsrud B, Akselsen HE, Rønningen KS, Sollid LM, Undlien DE (2006)
FOXP3 polymorphisms in type 1 diabetes and coeliac disease
J Autoimmun, 27 (2), 140-4
DOI 10.1016/j.jaut.2006.06.007, PubMed 16996248

Publications 2000

Olbjørn C, Bjørnvold M, Wathne KO, Gaustad P, Abrahamsen TG (2000)
[Tuberculosis in Norwegian children--diagnostic challenges]
Tidsskr Nor Laegeforen, 120 (15), 1721-5
PubMed 10904656